Transperitoneal transport of glucose in vitro.
The effect of fluid mixing intensification, damage of mesothelial cells, gentamicin, and icodextrin on the diffusive glucose transport across the peritoneal membrane were evaluated in in vitro studies. A mathematical model of mass transport was used to calculate the diffusive permeability, expressed as a diffusive permeability coefficient (P). In the control conditions, the rate of glucose transfer from the interstitial to the mesothelial side of membrane (I-->M) and in the opposite direction (M-->I) remained constant, and the P value at mean was 2,731 +/- 1,493 x 10-4 (cm x s-1). The change of the stirring rate from 5.5 to 11 ml/min increased P values by about 74% for transport direction I-->M and 58% for M-->I, and the change from 11 to 22 ml/min enhanced P at mean by about 42% for both directions. The damage of the mesothelial layer, using sodium deoxycholate (2.5 mmol/L; 103.6 mg%), increased the glucose transfer from the interstitial to the mesothelial side of the peritoneum by 41% and to the opposite direction by 70%. Addition of icodextrin to the glucose solution increased glucose bidirectional transport at mean by about 14% for I-->M and 24% for M-->I. Furthermore, gentamicin did not change the I-->M transfer, but diminished M-->I transport by about 12%. In conclusion, the reduction of unstirred fluid layers at the mesothelium and the interstitium-fluid interfaces, removal of mesothelium, and addition of icodextrin increased the diffusive glucose transport in vitro; unstirred fluid layers restricted glucose transfer (I-->M) more than the mesothelium; and peritoneal glucose transport, directed from the mesothelial to the interstitial side of the peritoneum, decreased slightly after the addition of gentamicin.
Czyzewska
K
K
Department of Clinical Biochemistry, Karol Marcinkowski University of Medical Sciences, Poznań, Poland.
Szary
B
B
Waniewski
J
J
D000465:Algorithms; D000704:Analysis of Variance; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D003840:Deoxycholic Acid / Q000494:pharmacology; D003902:Detergents / Q000494:pharmacology; D015314:Dialysis Solutions / Q000494:pharmacology; D004058:Diffusion; D015194:Diffusion Chambers, Culture; D004848:Epithelium / Q000187:drug effects / Q000378:metabolism; D005839:Gentamicins / Q000494:pharmacology; D005936:Glucans / Q000494:pharmacology; D005947:Glucose / Q000493:pharmacokinetics* / Q000494:pharmacology; D000077607:Icodextrin; D016014:Linear Models; D008954:Models, Biological; D010537:Peritoneum / Q000187:drug effects / Q000378:metabolism*; D010539:Permeability; D011817:Rabbits
D000900:Anti-Bacterial Agents; D003902:Detergents; D015314:Dialysis Solutions; D005839:Gentamicins; D005936:Glucans; D003840:Deoxycholic Acid; D000077607:Icodextrin; D005947:Glucose